Biogen Asks FDA To Approve Aducanumab
RESEARCH NEWS 2020-07-08 Research News Biogen announced today that it had submitted a biologics license application to the U.S. Food and Drug Administration for aducanumab, a therapeutic antibody developed to clear amyloid plaques from the brain. The Cambridge, Massachusetts, bio